Published in Hum Mol Genet on October 12, 2015
Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity. J Huntingtons Dis (2016) 0.85
Huntington disease. J Neuropathol Exp Neurol (1998) 6.54
PSD-95 involvement in maturation of excitatory synapses. Science (2000) 6.15
The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron (1992) 5.26
Stably maintained dendritic spines are associated with lifelong memories. Nature (2009) 5.16
Rapid formation and selective stabilization of synapses for enduring motor memories. Nature (2009) 4.96
Balancing structure and function at hippocampal dendritic spines. Annu Rev Neurosci (2008) 4.38
Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron (2007) 2.93
Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A (1988) 2.78
Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci U S A (1997) 2.77
Regulation of dendritic spine morphology by the rho family of small GTPases: antagonistic roles of Rac and Rho. Cereb Cortex (2000) 2.66
PSD-95 is required for activity-driven synapse stabilization. Proc Natl Acad Sci U S A (2007) 2.56
The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis. Neuron (2001) 2.52
A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J Neurosci (2005) 2.48
Dynamic aspects of CNS synapse formation. Annu Rev Neurosci (2007) 2.47
Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus. J Neurosci (2007) 2.39
An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling. Mol Cell Neurosci (2009) 2.28
The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat Neurosci (2004) 2.26
Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science (1985) 2.23
SAP90, a rat presynaptic protein related to the product of the Drosophila tumor suppressor gene dlg-A. J Biol Chem (1993) 2.17
Clinical markers of early disease in persons near onset of Huntington's disease. Neurology (2001) 2.11
Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2006) 1.99
The corticostriatal pathway in Huntington's disease. Prog Neurobiol (2006) 1.99
Mechanisms of synapse assembly and disassembly. Neuron (2003) 1.98
Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci (2003) 1.88
The Rac1 guanine nucleotide exchange factor Tiam1 mediates EphB receptor-dependent dendritic spine development. Proc Natl Acad Sci U S A (2007) 1.88
Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain (1998) 1.84
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci (2005) 1.82
Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection". Neuroimage (2009) 1.72
Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease. Nat Med (2014) 1.67
Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study. J Neurol (2004) 1.64
Kalirin, a multifunctional Rho guanine nucleotide exchange factor, is necessary for maintenance of hippocampal pyramidal neuron dendrites and dendritic spines. J Neurosci (2003) 1.60
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect. Trends Neurosci (2004) 1.58
Kalirin-7 is required for synaptic structure and function. J Neurosci (2008) 1.54
Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J Neurosci (2001) 1.52
An isoform of kalirin, a brain-specific GDP/GTP exchange factor, is enriched in the postsynaptic density fraction. J Biol Chem (2000) 1.50
Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol (2003) 1.49
Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc Natl Acad Sci U S A (2009) 1.49
Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb Cortex (2004) 1.48
Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. J Neurosci (1989) 1.46
Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci (1991) 1.45
Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. J Neurosci (2009) 1.43
Convergent CaMK and RacGEF signals control dendritic structure and function. Trends Cell Biol (2008) 1.38
Modular transport of postsynaptic density-95 clusters and association with stable spine precursors during early development of cortical neurons. J Neurosci (2001) 1.36
Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann Neurol (1995) 1.36
Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry (2004) 1.35
Profile of cognitive progression in early Huntington's disease. Neurology (2003) 1.35
Kalirin-7 is an essential component of both shaft and spine excitatory synapses in hippocampal interneurons. J Neurosci (2008) 1.33
Impaired learning of a motor skill in patients with Huntington's disease. Behav Neurosci (1988) 1.32
Executive and mnemonic functions in early Huntington's disease. Brain (1996) 1.30
Rapid labeling of neuronal populations by ballistic delivery of fluorescent dyes. Methods (2003) 1.28
Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci (2009) 1.28
Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice. Eur J Neurosci (2004) 1.27
Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production. Exp Neurol (2001) 1.27
Behavioral and morphological responses to cocaine require kalirin7. Biol Psychiatry (2010) 1.21
Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum Mol Genet (1997) 1.21
Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. J Neurosci Res (2004) 1.17
Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain (1997) 1.15
Intact mirror-tracing and impaired rotary-pursuit skill learning in patients with Huntington's disease: evidence for dissociable memory systems in skill learning. Neuropsychology (1997) 1.15
Kalirin is under-expressed in Alzheimer's disease hippocampus. J Alzheimers Dis (2007) 1.14
Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain (2000) 1.12
Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition. Mol Psychiatry (2011) 1.09
Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year. Acta Neurol Scand (2002) 1.07
Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease. J Neurophysiol (2005) 1.06
Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice. J Neurosci (2005) 1.04
Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models. Nat Med (2013) 1.04
Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. J Neurol Neurosurg Psychiatry (1998) 1.04
Subcellular distribution of spinophilin immunolabeling in primate prefrontal cortex: localization to and within dendritic spines. J Comp Neurol (2004) 1.04
Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study. Neurology (1993) 1.03
Structural plasticity of dendritic spines: the underlying mechanisms and its dysregulation in brain disorders. Biochim Biophys Acta (2013) 1.02
Kalirin loss results in cortical morphological alterations. Mol Cell Neurosci (2009) 1.01
Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity. Hum Mol Genet (2011) 1.01
Cognitive procedural learning in patients with fronto-striatal lesions. Learn Mem (2002) 1.00
Impaired planning but intact decision making in early Huntington's disease: implications for specific fronto-striatal pathology. Neuropsychologia (2000) 0.99
Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience (2008) 0.97
Neuropsychological characteristics of Huntington's disease carriers: a double blind study. J Med Genet (1995) 0.96
Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease. Hum Mol Genet (2011) 0.96
Kalirin-7, an important component of excitatory synapses, is regulated by estradiol in hippocampal neurons. Hippocampus (2010) 0.96
Structure and function of dendritic spines within the hippocampus. Ann Anat (2009) 0.95
Development of neuropsychological deficits in Huntington's disease. Arch Neurol (1983) 0.93
Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction. J Clin Invest (2014) 0.92
β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiol Aging (2012) 0.91
Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease. J Neurosci (2013) 0.91
Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease. J Neurol Neurosurg Psychiatry (2009) 0.90
Kalirin-7 is necessary for normal NMDA receptor-dependent synaptic plasticity. BMC Neurosci (2011) 0.89
Kalirin-7 mediates cocaine-induced AMPA receptor and spine plasticity, enabling incentive sensitization. J Neurosci (2013) 0.88
Abnormal explicit but normal implicit sequence learning in premanifest and early Huntington's disease. Mov Disord (2010) 0.85
Synapses, spines and kinases in mammalian learning and memory, and the impact of aging. Neurosci Biobehav Rev (2014) 0.84
Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice. Neurobiol Dis (2004) 0.84
Experimental models of HD and reflection on therapeutic strategies. Int Rev Neurobiol (2011) 0.84
Learning improvement after PI3K activation correlates with de novo formation of functional small spines. Front Mol Neurosci (2014) 0.82
Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease. Mol Neurobiol (2013) 0.80
Clinical Genetics, II. Huntington's disease: from the gene to pathophysiology. Am J Psychiatry (1997) 0.79
Centenary of the synapse: from Sherrington to the molecular biology of the synapse and beyond. Trends Neurosci (1997) 0.79
Stabilizing effects of extracellular ATP on synaptic efficacy and plasticity in hippocampal pyramidal neurons. Eur J Neurosci (2005) 0.79
Kalirin signaling: implications for synaptic pathology. Mol Neurobiol (2011) 0.79